Shree Ganesh Bio-Tech Fair Value
Shree Ganesh Bio-Tech (SHREEGANES) average fair value is ₹17.03 across 6 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF), vs a current market price of ₹0.56 (+2940.48%), fair value range ₹0.21–₹44.32. Check SHREEGANES market cap trends to track the company's total market size over time.
Fair Value Analysis Export
SHREEGANES Fair Value vs Current Price — Valuation Summary
SHREEGANES average fair value, fair value range, price gap and valuation status across 6 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF).
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
Discounted Cash Flow (DCF)
SHREEGANES Fair Value Analysis — Data Sources & Coverage
Shree Ganesh Bio-Tech financial data sources, valuation methods applied and sector benchmarks used — 2026 financial year. For live price and a broader fundamental view, visit Shree Ganesh Bio-Tech share price today.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
Data Currency: Financial data is from the current year (2026).
SHREEGANES vs Healthcare Sector Peers — P/E, P/B & Market Cap
Shree Ganesh Bio-Tech P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Syngene International | SYNGENE | 53.59 | 3.51 | ₹17,138 |
| Sat Kartar Life | SATKARTAR | 12.23 | 3.06 | ₹209 |
| Cohance Lifesciences | COHANCE | 114.67 | 4.4 | ₹16,787 |
| Divis Laboratories | DIVISLAB | 70.67 | 10.83 | ₹184,195 |
| SMS Lifesciences | SMSLIFE | 22.27 | 1.82 | ₹354 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.